ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Alturas Minerals Corp

Alturas Minerals Corp (ALT)

0,005
-0,005
(-50,00%)
Geschlossen 14 November 10:00PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,005
Gebot
0,005
Fragen
0,01
Volumen
12.000
0,005 Tagesbereich 0,005
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
0,01
Handelsbeginn
0,005
Letzte Trade
11000
@
0.005
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
145.632.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-0
Erlöse
-
Nettogewinn
-487k

Über Alturas Minerals Corp

Sektor
Miscellaneous Metal Ores,nec
Branche
Mining & Extracting Div'e
Hauptsitz
Toronto, Ontario, Can
Gegründet
1996
Alturas Minerals Corp is listed in the Miscellaneous Metal Ores sector of the TSX Venture Börse with ticker ALT. The last closing price for Alturas Minerals was $0,01. Over the last year, Alturas Minerals shares have traded in a share price range of $ 0,00 to $ 0,00.

Alturas Minerals currently has 145.632.000 shares in issue. The market capitalisation of Alturas Minerals is $1,46 million. Alturas Minerals has a price to earnings ratio (PE ratio) of 0.00.

ALT Neueste Nachrichten

/C O R R E C T I O N -- Alteon, Inc./

In the news release, Alteon Signs Agreements for Sale of Approximately $1.4 Million in Common Stock PIPE Transaction, issued earlier today by Alteon, Inc. over PR Newswire, we are advised by the...

Alteon Updates Investors on Alagebrium Development Status

Alteon Updates Investors on Alagebrium Development Status - Alagebrium Preclinical Toxicity Tests Progressing; Company Intends to Perform SPECTRA Clinical Trial Interim Analysis - PARSIPPANY...

Alteon Announces Year-End and Fourth Quarter Results

Alteon Announces Year-End and Fourth Quarter Results PARSIPPANY, N.J., March 15 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX: ALT) announced today a net loss of $13,958,646 for the year ended...

Alteon Initiates Phase 2 Trial of Alagebrium in Erectile Dysfunction

Alteon Initiates Phase 2 Trial of Alagebrium in Erectile Dysfunction - 'EMERALD' Trial to Test the Efficacy of Alagebrium in Diabetic Men Who Achieve Limited Benefit from Current Therapies...

Alteon to Present at the Credit Suisse First Boston Healthcare Conference Friday, November 19, 2004

Alteon to Present at the Credit Suisse First Boston Healthcare Conference Friday, November 19, 2004 PARSIPPANY, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX: ALT) announced today...

Alteon Issued Key Composition-of-Matter Patent Covering Additional A.G.E. Crosslink Breakers to Treat Diseases of Aging and Diab

Alteon Issued Key Composition-of-Matter Patent Covering Additional A.G.E. Crosslink Breakers to Treat Diseases of Aging and Diabetes PARSIPPANY, N.J., Sept. 20 /PRNewswire-FirstCall/ -- Alteon...

Alteon to Change Principal Accountants

Alteon to Change Principal Accountants PARSIPPANY, N.J., Aug. 13 /PRNewswire-FirstCall/ -- Alteon Inc. today announced that KPMG LLP ("KPMG") has informed the company that it has resigned as...

Alteon Announces Resignation of Senior Vice President Robert C. deGroof, Ph.D.

Alteon Announces Resignation of Senior Vice President Robert C. deGroof, Ph.D. PARSIPPANY, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Alteon Inc. today announced the resignation of Robert C...

Alteon's Investigational Drugs Demonstrate Ability to Reduce Atherosclerosis

Alteon's Investigational Drugs Demonstrate Ability to Reduce Atherosclerosis - Preclinical Study in 'Diabetes' Also Identifies Important Role of Sugar in Atherosclerosis - PARSIPPANY, N.J., June...

Detailed Data on Alteon's Hypertension/Heart Failure Drug Candidate Alagebrium to Be Presented at The American Society of Hypert

Detailed Data on Alteon's Hypertension/Heart Failure Drug Candidate Alagebrium to Be Presented at The American Society of Hypertension Meeting PARSIPPANY, N.J., April 27 /PRNewswire-FirstCall/...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
JHCJinhua Capital Corporation
$ 0,01
(100,00%)
89k
UIGUrban Infrastructure Group Inc
$ 0,075
(87,50%)
2k
BKMTBlockmint Technologies Inc
$ 0,085
(70,00%)
703,8k
MATEBlockmate Ventures Inc
$ 0,075
(66,67%)
5,65M
BAV.HBravern Ventures Ltd
$ 0,25
(56,25%)
122,5k
ETUE2gold Inc
$ 0,005
(-50,00%)
161,91k
WWTWater Ways Technologies Inc
$ 0,005
(-50,00%)
6,58k
EGTEguana Technologies Inc
$ 0,005
(-50,00%)
25,3k
ALTAlturas Minerals Corp
$ 0,005
(-50,00%)
12k
AAA.PFirst Tidal Acquisition Corp
$ 0,05
(-50,00%)
500
MATEBlockmate Ventures Inc
$ 0,075
(66,67%)
5,65M
DEALPlaygon Games Inc
$ 0,01
(0,00%)
4,7M
CTMCanterra Minerals Corp
$ 0,07
(55,56%)
4,09M
AECAnfield Energy Inc
$ 0,11
(10,00%)
3,74M
GSVRGuanajuato Silver Company Ltd
$ 0,21
(-6,67%)
3,63M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen